☆ 4.8 Article

Ciprofloxacin Derivative-Loaded Nanoparticles Synergize with Paclitaxel Against Type II Human Endometrial Cancer

SMALL (2023)

Related references

Note: Only part of the references are listed.

Article Engineering, Biomedical

A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer

Suhaila O. Alhaj-Suliman et al.

Summary: Dysfunction of p53 gene and presence of MDR1 gene are associated with many malignant tumors, including endometrial cancer, and contribute to drug resistance. A new ciprofloxacin derivative, CIP2b, in combination with taxanes, showed synergistic cytotoxic effects against endometrial cancer cells with MDR1 expression and loss-of-function p53. CIP2b targets multiple pathways and enhances the effects of paclitaxel on microtubule assembly.

BIOMATERIALS (2023)

Add to Collection

Review Medicine, Research & Experimental

Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies

Luman Liu et al.

Summary: Pancreatic tumors are difficult to treat due to their highly fibrotic and immunosuppressive nature. Nanotechnology offers promising solutions by providing improved drug delivery and immunotherapy-based approaches. This review highlights the potential of nanoscale strategies for treating pancreatic tumors and discusses future research directions.

THERANOSTICS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization

Hamada H. H. Mohammed et al.

Summary: The novel ciprofloxacin hybrids demonstrated remarkable anti-proliferative activity against colon cancer cells by inhibiting topoisomerase and tubulin polymerization, suggesting their potential as novel anticancer agents. Their mechanism of action involves DNA damage and cell cycle arrest through the ATR/CHK1/Cdc25C pathway.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Multidisciplinary Sciences

Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine

Rasheid Smith et al.

Summary: Nanoscale formulations can enhance the efficacy of cancer vaccines by combating the immunosuppressive nature of the tumor microenvironment. A newly synthesized nanoparticulate formulation demonstrated adjuvant properties in vivo, leading to increased TAA-specific T cells, reduced tumor burden, protection against tumor rechallenge, and improved median survival in tumor-challenged mice.

SCIENCE ADVANCES (2022)

Add to Collection

Review Pharmacology & Pharmacy

Engineering nanosystems to overcome barriers to cancer diagnosis and treatment

Suhaila O. Alhaj-Suliman et al.

Summary: In the past two decades, there has been increasing interdisciplinary research on the development of nanoparticles for medical applications. However, nanoparticles still face biological barriers and biodistribution challenges, limiting their overall clinical potential. To overcome these limitations, innovative modifications have been made to nanoparticle formulations designed for cancer imaging and treatment, aiming to enhance specificity and target diseased tissues. Recent advancements in technology and chemistry have been employed to modify the surface and characteristics of nanoparticles, in combination with identifying critical biomarkers, providing new strategies for improving nanoparticle specificity in cancer diagnosis and therapy. This review discusses the latest advances in nanoparticle design and engineering, and outlines future directions for the development of next-generation nanomedicines.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Add to Collection

Article Engineering, Biomedical

Light-activatable liposomes for repetitive on-demand drug release and immunopotentiation in hypoxic tumor therapy

Yuanyuan Yang et al.

Summary: A multifunctional light-activatable liposome has been engineered for repetitive on-demand drug release under discontinuous light irradiation, allowing for chemo-photodynamic therapy and immunopotentiation in hypoxic tumors. This system effectively remodels the redox balance in tumors, alleviating hypoxia and enhancing PDT efficacy, reversing cisplatin resistance, and polarizing tumor-associated macrophages to the immunocompetent M1 phenotype.

BIOMATERIALS (2021)

Add to Collection

Article Chemistry, Physical

Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer

Wen Ma et al.

Summary: In this study, a self-targeting hyaluronate nanogel was developed for reversing drug resistance through synchronized pharmacokinetics, intratumoral distribution, and intracellular release of doxorubicin and cisplatin. This nanogel showed efficient drug delivery into drug-resistant breast cancer cells and enhanced antitumor activity, with potential for future clinical therapy of advanced cancers. Visualized synchronized drug delivery and imaging techniques facilitate the visualization of combination tumor chemotherapy.

NANO RESEARCH (2021)

Add to Collection

Article Pharmacology & Pharmacy

Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy

Ling Yu et al.

Summary: A photo-activatable liposome incorporating both photosensitizer Ce6 and chemotherapeutic drug TP was designed for controlled drug release and synergistic photodynamic therapy in treating HCC. This novel approach showed improved therapeutic effects with reduced side effects, making it a potential treatment option for HCC.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Review Health Care Sciences & Services

The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery-Personal Remarks and Future Prospects

Hiroshi Maeda

Summary: This review highlights the importance of restoring tumor blood flow to improve drug delivery and discusses the differences between small animal cancer models and large clinical cancers in humans. It also emphasizes the unique tumor-selective drug delivery method of arterial infusion and how it is personalized for each individual patient. Future developments in EPR effect-based treatment are expected to range from chemotherapy to photodynamic therapy, boron neutron capture therapy, and therapies for free radical diseases.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice

Aml Mekkawy et al.

Summary: The study explores the efficacy of a combination therapy of PTX and PD98059 in enhancing cytotoxicity against melanoma cells expressing the BRAF mutation. The use of PD98059-loaded NPs showed superior cellular uptake and cytotoxicity compared to soluble PD98059, suggesting a potential therapeutic approach for improving survival outcomes in patients with metastatic melanoma.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Thiophene Derivative-Loaded Nanoparticles Mediate Anticancer Activity Through the Inhibition of Kinases and Microtubule Assembly

Somaya A. Abdel-Rahman et al.

Summary: Different tetrahydrobenzo[b]thiophene derivatives, especially the benzyl urea derivative BU17, have been identified as potent antitumor compounds with broad-spectrum activity against several cancer cell lines through inhibiting tubulin polymerization. BU17 induces apoptosis, potentially by targeting WEE1 kinase and tubulin. Furthermore, BU17-loaded PLGA nanoparticles exhibit significantly enhanced antitumor activity compared to the soluble form.

ADVANCED THERAPEUTICS (2021)

Add to Collection

Review Pharmacology & Pharmacy

Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers

Jun Fang et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Add to Collection

Review Medicine, General & Internal

Endometrial Cancer

Karen H. Lu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Editorial Material Nanoscience & Nanotechnology

CANCER NANOMEDICINE A synthetic lethal bullet

Christian Rolfo et al.

NATURE NANOTECHNOLOGY (2018)

Add to Collection

Article Nanoscience & Nanotechnology

Synthetically lethal nanoparticles for treatment of endometrial cancer

Kareem Ebeid et al.

NATURE NANOTECHNOLOGY (2018)

Add to Collection

Article Oncology

Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy

Kerri M. Winters-Stone et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Polymer therapeutics and the EPR effect

Hiroshi Maeda

JOURNAL OF DRUG TARGETING (2017)

Add to Collection

Article Multidisciplinary Sciences

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

Antoine Daina et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

New antiproliferative 7-(4-(N-substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2/M phase

Hamada H. H. Mohammed et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

Add to Collection

Article Pathology

Recommendations from the INHAND Apoptosis/Necrosis Working Group

Susan A. Elmore et al.

TOXICOLOGIC PATHOLOGY (2016)

Add to Collection

Article Oncology

Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity

Youssef W. Naguib et al.

NEOPLASIA (2016)

Add to Collection

Review Pharmacology & Pharmacy

Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity

Hiroshi Maeda

ADVANCED DRUG DELIVERY REVIEWS (2015)

Add to Collection

Review Oncology

Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer

Edgardo Rivera et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)

Add to Collection

Article Oncology

Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group

Ignace Vergote et al.

GYNECOLOGIC ONCOLOGY (2015)

Add to Collection

Article Chemistry, Multidisciplinary

Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo

Rebecca Klippstein et al.

SMALL (2015)

Add to Collection

Review Oncology

Classification of endometrial carcinoma: more than two types

Rajmohan Murali et al.

LANCET ONCOLOGY (2014)

Add to Collection

Article Medicine, Research & Experimental

Solid Lipid Nanoparticle Formulations of Docetaxel Prepared with High Melting Point Triglycerides: In Vitro and in Vivo Evaluation

Youssef Wahib Naguib et al.

MOLECULAR PHARMACEUTICS (2014)

Add to Collection

Article Oncology

Type I and II Endometrial Cancers: Have They Different Risk Factors?

Veronica Wendy Setiawan et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Add to Collection

Article Chemistry, Multidisciplinary

Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery

Sneha A. Kulkarni et al.

PHARMACEUTICAL RESEARCH (2013)

Add to Collection

Review Pharmacology & Pharmacy

Strategies to Address Low Drug Solubility in Discovery and Development

Hywel D. Williams et al.

PHARMACOLOGICAL REVIEWS (2013)

Add to Collection

Review Engineering, Biomedical

Vitamin E TPGS as a molecular biomaterial for drug delivery

Zhiping Zhang et al.

BIOMATERIALS (2012)

Add to Collection

Review Pharmacology & Pharmacy

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

Jun Fang et al.

ADVANCED DRUG DELIVERY REVIEWS (2011)

Add to Collection

Article Pharmacology & Pharmacy

In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles

Brian R. Sloat et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)

Add to Collection

Article Engineering, Biomedical

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel

Si-Shen Feng et al.

BIOMATERIALS (2009)

Add to Collection

Review Pharmacology & Pharmacy

Solubility of sparingly-soluble ionizable drugs

Alex Avdeef

ADVANCED DRUG DELIVERY REVIEWS (2007)

Add to Collection

Article Health Care Sciences & Services

Preventing paclitaxel-induced peripheral neuropathy: A phase II trial of vitamin E supplementation

Andreas A. Argyriou et al.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)

Add to Collection

Article Neurosciences

Peripheral neuropathy induced by paclitaxel: Recent insights and future perspectives

CD Scripture et al.

CURRENT NEUROPHARMACOLOGY (2006)

Add to Collection

Review Oncology

Peripheral neuropathy induced by microtubule-stabilizing agents

JJ Lee et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.